ABSTRACT
No disponible
Subject(s)
Humans , Liver Cirrhosis/physiopathology , Biopsy/methods , Hepatitis C, Chronic/complications , Disease Progression , Fatty Liver/epidemiology , Biomarkers/analysisABSTRACT
No disponible
No disponible
Subject(s)
Female , Humans , Male , Therapeutics/mortality , Therapeutics/nursing , Hepatitis C, Chronic/blood , Hepatitis C, Chronic/transmission , Carcinoma, Hepatocellular/congenital , Carcinoma, Hepatocellular/pathology , Pharmaceutical Preparations/administration & dosage , Therapeutics/instrumentation , Therapeutics/methods , Hepatitis C, Chronic/metabolism , Hepatitis C, Chronic/pathology , Carcinoma, Hepatocellular/complications , Carcinoma, Hepatocellular/diagnosis , Pharmaceutical PreparationsABSTRACT
Nodular regenerative hyperplasia (NRH) of the liver is an infrequent entity that is usually diagnosed after the appearance of clinical signs of portal hypertension such as hepatomegaly, splenomegaly or upper gastrointestinal bleeding due to esophageal varices, which are the most frequently found clinical manifestations in NRH. Ascites is a less frequent finding and has always been described in association with other manifestations of portal hypertension. We describe a new case of NRH with atypical presentation in which ascites was the sole clinical manifestation.
Subject(s)
Ascites/etiology , Focal Nodular Hyperplasia/diagnosis , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Bronchopneumonia/complications , Combined Modality Therapy , Disease Progression , Fatal Outcome , Focal Nodular Hyperplasia/etiology , Focal Nodular Hyperplasia/pathology , Humans , Hypertension, Portal/etiology , Liver Regeneration , Lumbar Vertebrae , Male , Melphalan/administration & dosage , Melphalan/adverse effects , Multiple Myeloma/complications , Multiple Myeloma/drug therapy , Plasmacytoma/complications , Plasmacytoma/drug therapy , Plasmacytoma/radiotherapy , Prednisone/adverse effects , Spinal Neoplasms/complications , Spinal Neoplasms/drug therapy , Spinal Neoplasms/radiotherapyABSTRACT
We show the results of a retrospective study carried out during ten years (1978-1987), in Catalonia in the provinces of Barcelona and Gerona. The aim of the study was to evaluate the incidence and prevalence of inflammatory chronic bowel disease in our country, its clinical aspects, management and long term survival. An epidemiological inquiry was sent to all the hospitals and gastroenterologists of Catalonia. Nine hundred and seventy six answers were received from 20 Hospitals and four specialists. All of them were revised by the Research Committee, and 761 were validated for their inclusion in the study. The prevalence of the disease was similar both in Barcelona (19 per 100,000) and Gerona (18 per 100,000). The incidence of ulcerative colitis increased during the study, from 0.4 in 1978 to 0.8 in 1987, with a peak of maximum incidence (1.0 per 100,000) in 1985. In the same way, an increase in the incidence of Crohn's disease from 0.2 to 0.7 per 100,000, was observed. The mean incidence per year was 0.6 and 0.4 respectively, similar to the incidence observed in other Spanish regions during the same period of time. Finally we show the most important clinical and therapeutic aspects as well as the survival data.
